The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Open accessAbstract
Cancer stem cell population is a subset of cells capable of dictating invasion, metastasis, heterogeneity, and therapeutic resistance in tumours. Eradication of this rare population is a new insight in cancer treatment. However, prospective identification, characterization, and isolation of these CSCs have been a major challenge. Many studies were performed on surface markers for potential identification and isolation of CSCs. Lack of universal expression of surface markers limits their usage and no best combination of markers has yet been confirmed to identify CSCs capable of initiating and metastasizing tumours. CD44, a hyaluronic acid receptor, is one of the most commonly studied surface markers, which is expressed by almost every tumour cell. CD24, a heat stable antigen, is another surface marker expressed in many tumour types. However, their expression and prognostic value in isolating CSCs are still an enduring ambiguity. In this critical review, we assess the role of CD44 and CD24 in tumour initiation, development, and metastasis. We mainly focus on analysing the significance of CD44 and CD24 as CSC surface markers in combination or with other putative markers in different types of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,584
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Reactive oxygen species: role in the development of cancer and various chronic conditions.
Waris, G., & Ahsan, H. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-14 · Cited by 1,459
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Fillmore, C. M., & Kuperwasser, C. (2008) · Breast Cancer Research · doi:10.1186/bcr1982 · Cited by 1,033
Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Badve, S., & Nakshatri, H. (2006) · Breast Cancer Research · doi:10.1186/bcr1610 · Cited by 993
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J. G., Chandra, D., Zhou, J., Claypool, K., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209327 · Cited by 968
Silber, J., Lim, D. A., Petritsch, C., Persson, A. I., Maunakea, A. K., Yu, M., Vandenberg, S. R., Ginzinger, D. G., James, C. D., Costello, J. F., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-14 · Cited by 957
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
Ricardo, S., Vieira, A. F., Gerhard, R., Leitão, D., Pinto, R., Cameselle-Teijeiro, J. F., Milanezi, F., Schmitt, F., & Paredes, J. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2011.090456 · Cited by 619
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1034 · Cited by 588
Springer, T., Galfrè, G., Secher, D. S., & Milstein, C. (1978) · European Journal of Immunology · doi:10.1002/eji.1830080802 · Cited by 576
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Honeth, G., Bendahl, P.-O., Ringnér, M., Saal, L. H., Gruvberger-Saal, S. K., Lövgren, K., Grabau, D., Fernö, M., Borg, Å., & Hegardt, C. (2008) · Breast Cancer Research · doi:10.1186/bcr2108 · Cited by 551
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 527
Croker, A. K., Goodale, D., Chu, J., Postenka, C., Hedley, B. D., Hess, D. A., & Allan, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00455.x · Cited by 525
Alvero, A. B., Chen, R., Fu, H.-H., Montagna, M., Schwartz, P. E., Rutherford, T., Silasi, D.-A., Steffensen, K. D., Waldstrom, M., Visintin, I., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7533 · Cited by 489
Cancer stem cells from colorectal cancer-derived cell lines
Yeung, T. M., Gandhi, S. C., Wilding, J. L., Muschel, R., & Bodmer, W. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915135107 · Cited by 488
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Leung, E. L.-H., Fiscus, R. R., Tung, J. W., Tin, V. P.-C., Cheng, L. C., Sihoe, A. D.-L., Fink, L. M., Ma, Y., & Wong, M. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014062 · Cited by 473
Godar, S., Ince, T. A., Bell, G. W., Feldser, D., Donaher, J. L., Bergh, J., Liu, A., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 456
Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B., & Farrar, W. L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604242 · Cited by 437
Cancer stem cell markers in common cancers – therapeutic implications
Klonisch, T., Wiechec, E., Hombach-Klonisch, S., Ande, S. R., Wesselborg, S., Schulze-Osthoff, K., & Los, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.003 · Cited by 393
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
Gao, M.-Q., Choi, Y.-P., Kang, S., Youn, J. H., & Cho, N.-H. (2010) · Oncogene · doi:10.1038/onc.2010.35 · Cited by 392
Lee, C. J., Dosch, J., & Simeone, D. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6702 · Cited by 374
Baumann, P., Cremers, N., Kroese, F., Orend, G., Chiquet-Ehrismann, R., Uede, T., Yagita, H., & Sleeman, J. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0619 · Cited by 333
Breast cancer stem cells revealed
Dick, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830967100 · Cited by 319
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
Naor, D., Wallach-Dayan, S. B., Zahalka, M. A., & Sionov, R. V. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.015 · Cited by 309
CD24 expression is a new prognostic marker in breast cancer.
Kristiansen, G., Winzer, K., Mayordomo, É., Bellach, J., Schlüns, K., Denkert, C., Dahl, E., Pilarsky, C. P., Altevogt, P., Guski, H., et al. (2003) · PubMed · Cited by 306
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
CD24 mediates rolling of breast carcinoma cells on P‐selectin
Aigner, S., Ramos, C. L., Hafezi‐Moghadam, A., Lawrence, M. B., Friederichs, J., Altevogt, P., & Ley, K. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1241 · Cited by 282
Fang, X., Zheng, P., Tang, J., & Liu, Y. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.119 · Cited by 274
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells
Gal, H., Pandi, G., Kanner, A. A., Ram, Z., Lithwick-Yanai, G., Amariglio, N., Rechavi, G., & Givol, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.107 · Cited by 234
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Shipitsin, M., & Polyak, K. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.14 · Cited by 231
Klarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., Thomas, S. B., & Farrar, W. L. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9242-2 · Cited by 221
Watson, J. M., Sensintaffar, J., Berek, J. S., & Martı́nez-Maza, O. (1990) · PubMed · Cited by 221
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Stewart, J. M., Shaw, P. A., Gedye, C., Bernardini, M. Q., Neel, B. G., & Ailles, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005529108 · Cited by 209
Choi, D., Lee, H. W., Hur, K. Y., Kim, J. J., Park, G.-S., Jang, S.-H., Song, Y. S., Jang, K.-S., & Paik, S. S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2258 · Cited by 203
Kaller, M., Liffers, S.-T., Oeljeklaus, S., Kuhlmann, K., Röh, S., Hoffmann, R., Warscheid, B., & Hermeking, H. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010462 · Cited by 201
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
Gao, A. C., Lou, W., Dong, J., & Isaacs, J. T. (1997) · PubMed · Cited by 197
More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules
Keysar, S. B., & Jimeno, A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0530 · Cited by 195
Strauss, R., Li, Z.-Y., Liu, Y., Beyer, I., Persson, J., Sova, P., Möller, T., Pesonen, S., Hemminki, A., Hamerlik, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016186 · Cited by 194
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells
Schabath, H., Runz, S., Joumaa, S., & Altevogt, P. (2006) · Journal of Cell Science · doi:10.1242/jcs.02741 · Cited by 190
Santini, M. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00078-0 · Cited by 189
Stem cells in prostate cancer initiation and progression
Lawson, D. A., & Witte, O. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32810 · Cited by 179
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J., & Schroeder, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0863 · Cited by 178
Breast cancer chemoresistance: Emerging importance of cancer stem cells
Chuthapisith, S., Eremin, J., El-Sheemey, M., & Eremin, O. (2010) · Surgical Oncology · doi:10.1016/j.suronc.2009.01.004 · Cited by 174
Mylona, E. E., Giannopoulou, I., Fasomytakis, E., Nomikos, A., Μagkou, C., Bakarakos, P., & Nakopoulou, L. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.12.003 · Cited by 174
Louie, E., Nik, S., Chen, J., Schmidt, M. M., Song, B., Pacson, C., Chen, X. F., Park, S.-H. E., Ju, J., & Chen, E. I. (2010) · Breast Cancer Research · doi:10.1186/bcr2773 · Cited by 162
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Dynamic regulation of CD24 and the invasive, CD44posCD24negphenotype in breast cancer cell lines
Meyer, M. J., Fleming, J. M., Ali, M. A., Pesesky, M. W., Ginsburg, E., & Vonderhaar, B. K. (2009) · Breast Cancer Research · doi:10.1186/bcr2449 · Cited by 152
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Yang, X., Xu, Y., Yu, B., Zhou, J., Li, J., Qiu, S., Shi, Y., Wang, X., Dai, Z., Shi, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0151 · Cited by 142
Absence of the CD44 gene prevents sarcoma metastasis.
Weber, G. F., Bronson, R. T., Ilagan, J., Cantor, H., Schmits, R., & Mak, T. W. (2002) · PubMed · Cited by 141
Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
Pham, P. V., Phan, N. L., Nhung, N. T., Truong, N. H., Duong, T. T., Le, D., Truong, K. D., & Phan, N. K. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-209 · Cited by 132
Hill, A., McFarlane, S., Mulligan, K., Gillespie, H., Draffin, J. E., Trimble, A., Ouhtit, A., Johnston, P. G., Harkin, D. P., McCormick, D., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209628 · Cited by 128
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures
Zhou, L., Jiang, Y., Yan, T., Di, G., Shen, Z., Shao, Z., & Lu, J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0999-4 · Cited by 120
Slomiany, M. G., Dai, L., Tolliver, L. B., Grass, G. D., Zeng, Y., & Toole, B. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2317 · Cited by 119
Overdevest, J. B., Thomas, S., Kristiansen, G., Hansel, D. E., Smith, S. C., & Theodorescu, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0519 · Cited by 119
Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina, I. L., Rowehl, R. A., Rivadeneira, D. E., Karpeh, M. S., Crawford, H. C., Dufour, A., Ju, J., Wang, Y., Leyfman, Y., & Botchkina, G. I. (2009) · PubMed · Cited by 107
Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
Stuelten, C. H., Mertins, S. D., Busch, J. I., Theofiles, M., Scudiero, D. A., Burkett, M. W., Hite, K. M., Alley, M., Hollingshead, M. G., Shoemaker, R. H., et al. (2010) · Stem Cells · doi:10.1002/stem.324 · Cited by 105
Selectin Ligand Expression Regulates the Initial Vascular Interactions of Colon Carcinoma Cells
Napier, S. L., Healy, Z. R., Schnaar, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607219200 · Cited by 103
Human ovarian cancer stem cells
Bapat, S. A. (2010) · Reproduction · doi:10.1530/rep-09-0389 · Cited by 103
Wei, X., Dombkowski, D., Meirelles, K., Pieretti‐Vanmarcke, R., Szotek, P. P., Chang, H. L., Preffer, F. I., Müeller, P. R., Teixeira, J. M., MacLaughlin, D. T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012667107 · Cited by 101
Chen, K., Pan, F., Jiang, H., Chen, J., Li, P. Z., Xie, F., & Liang, H. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9407-7 · Cited by 100
Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
Shi, M., Jiao, J., Lü, W., Ye, F., Ma, D., Dong, Q., & Xie, X. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0420-9 · Cited by 99
Lee, H. J., Choe, G., Jheon, S., Sung, S. W., Lee, C., & Chung, J.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d5e554 · Cited by 94
Banzato, A., Bobisse, S., Rondina, M. B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2019 · Cited by 92
The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response
Anderson, E. C., Hessman, C. J., Levin, T. G., Monroe, M. M., & Wong, M. H. (2011) · Cancers · doi:10.3390/cancers3010319 · Cited by 83
CD44-Targeted Microparticles for Delivery of Cisplatin to Peritoneal Metastases
Li, S., & Howell, S. B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900242f · Cited by 80
Ovarian cancer: emerging concept on cancer stem cells
Ponnusamy, M. P., & Batra, S. K. (2008) · Journal of Ovarian Research · doi:10.1186/1757-2215-1-4 · Cited by 80
Gunawardana, C. G., Kuk, C., Smith, C. R., Batruch, I., Soosaipillai, A. R., & Diamandis, E. P. (2009) · Journal of Proteome Research · doi:10.1021/pr900411g · Cited by 80
Vassilopoulos, A., Wang, R.-H., Petrovas, C., Ambrozak, D. R., Koup, R. A., & Deng, C. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.133 · Cited by 79
Botchkina, G. I., Zuniga, E. S., Das, M., Wang, Y., Wang, H., Zhu, S., Savitt, A. G., Rowehl, R. A., Leyfman, Y., Ju, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-192 · Cited by 78
Taniuchi, K., Nishimori, I., & Hollingsworth, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2743 · Cited by 74
Ween, M. P., Hummitzsch, K., Rodgers, R. J., Oehler, M. K., & Ricciardelli, C. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9363-7 · Cited by 69
Stefano, I. D., Battaglia, A., Zannoni, G. F., Prisco, M. G., Fattorossi, A., Travaglia, D., Baroni, S., Renier, D., Scambia, G., Ferlini, C., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1462-2 · Cited by 59
Microenvironmental Regulation of Ovarian Cancer Metastasis
Barbolina, M. V., Moss, N. M., Westfall, S. D., Liu, Y., Burkhalter, R. J., Marga, F. S., Forgács, G., Hudson, L. G., & Stack, M. S. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_15 · Cited by 58
CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMAS
Paradis, V., Ferlicot, S., GHANNAM, E., ZEIMOURA, L., Blanchet, P., Eschwège, P., Jardin, A., Benoît, G., & Bédossa, P. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68869-6 · Cited by 50
CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation
Ahmed, M. A. H., Jackson, D., Seth, R., Robins, A., Lobo, D. N., Tomlinson, I. P. M., & Ilyas, M. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21134 · Cited by 47
Pierres, M., Naquet, P., Barbet, J., Marchetto, S., Marics, I., Devaux, C. A., Barad, M., Hyman, R., & Rougon, G. N. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171216 · Cited by 43
Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
Cannistra, S. A., DeFranzo, B., Niloff, J. M., & Ottensmeir, C. (1995) · PubMed · Cited by 42
Targeting embryonic signaling pathways in cancer therapy
Harris, P. J., Speranza, G., & Ullmann, C. D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645808 · Cited by 42
Prostate tumor-initiating cells: A new target for telomerase inhibition therapy?
Marian, C. O., & Shay, J. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.012 · Cited by 42
Rainaldi, G., Calcabrini, A., Arancia, G., & Santini, M. T. (1999) · PubMed · Cited by 26
Expression Compilation of Several Putative Cancer Stem Cell Markers by Primary Ovarian Carcinoma
Jiabo, D., Refika, Y., Carl, G., Tjitske, D.-D. B., Leon, M., & Torensma, R. (2010) · Journal of Cancer Therapy · doi:10.4236/jct.2010.14026 · Cited by 9
Cited by
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 578
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 379
Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Cayrefourcq, L., Mazard, T., Joosse, S., Solassol, J., Ramos, J., Assenat, E., Schumacher, U., Costes, V., Maudelonde, T., Pantel, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2613 · Cited by 372
Metadata
- Authors
- Jaggupilli, A., & Elkord, E.
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- OpenAlex
- W2158569602
- Cited by
- 510
- References
- 106
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.